TY - JOUR
T1 - American thoracic society documents
T2 - Research needs on respiratory health in migrant and refugee populations An Official American Thoracic Society and European Respiratory Society Workshop Report
AU - Roman, Jesse
AU - Viegi, Giovanni
AU - Schenker, Marc
AU - Ojeda, Victoria D.
AU - Pérez-Stable, Eliseo J.
AU - Nemery, Benoit
AU - Annesi-Maesano, Isabella
AU - Patel, Sanjay R.
AU - La Grutta, Stefania
AU - Holguin, Fernando
AU - Moughrabieh, Anas
AU - Bime, Christian
AU - Lindberg, Anne
AU - Migliori, Giovanni B.
AU - De Vries, Gerard
AU - Ramírez, Julio
AU - Aliberti, Stefano
AU - Feldman, Charles
AU - Celedón, Juan C.
N1 - Funding Information:
research support from Boehringer Ingelheim, Gilead, Fibrogen, and Promedior; served as a consultant for Boehringer Ingelheim. S.R.P. received research support from Bayer, Philips Respironics, and ResMed Foundation; served on a data and safety monitoring board for Philips Respironics; served as a consultant for Medtronic. J. Ramírez served on an advisory committee for Achaogen, Nabriva, Paratek, Pfizer, and The Medicines Company; served as a speaker for Amgen and The Medicines Company; served as a consultant for Curetis and Pfizer; received research support from Pfizer. S.A. received research support from Aradigm, Bayer, Chisei, Grifols, and Insmed; received personal fees (unspecified) from Actavis UK, Aradigm, AstraZeneca, Basilea, Bayer, Chiesi, Grifols, Horizon, Insmed, Novartis, Raptor, and Zambon. C.F. served on an advisory committee for Abbott and AstraZeneca; served as a speaker for Aspen, GlaxoSmithKline, and Sanofi; served on an advisory committee and as a speaker for Pfizer and Pharma Dynamics. J.C.C. received research support from GlaxoSmithKline, Merck, and Pharmavite. G.V., M.S., V.D.O., E.J.P.-S., B.N., I.A.-M., S.L.G., F.H., A.M., C.B., A.L., G.B.M., and G.D.V. reported no relationships with relevant commercial interests.
Publisher Copyright:
© 2018 by the American Thoracic Society.
PY - 2018/11
Y1 - 2018/11
N2 - Migrants represent a diverse population comprising workers, students, undocumented individuals, and refugees. Worldwide, approximately 1 billion people were considered migrants in 2016. Notably, about 65 million of these migrants were forcibly displaced from their homes, and 20 million were considered refugees. While the geopolitical consequences of such migration continue to be considered, less is known about the impact of these events on the respiratory health of migrants and refugees. In recognition of this knowledge gap, the American Thoracic Society and the European Respiratory Society brought together investigators with diverse and relevant expertise to participate in a workshop and develop a consensus on research needs on the respiratory health of migrants and refugees. The workshop focused on environmental and occupational hazards, chronic noninfectious diseases, and respiratory infectious diseases, which were presented by experts in three distinct sessions, each culminating with panel discussions. A writing committee collected summaries prepared by speakers and other participants, and the information was collated into a single document. Recommendations were formulated, and differences were resolved by discussion and consensus. The group identified important areas of research need, while emphasizing that reducing the burden of pulmonary, critical care, and sleep disorders in migrants and refugees will require a concerted effort by all stakeholders. Using best research practices, considering how research impacts policies affecting migrant and refugee populations, and developing new approaches to engage and fund trainees, clinical investigators, and public health practitioners to conduct high-quality research on respiratory health of migrants and refugees is essential.
AB - Migrants represent a diverse population comprising workers, students, undocumented individuals, and refugees. Worldwide, approximately 1 billion people were considered migrants in 2016. Notably, about 65 million of these migrants were forcibly displaced from their homes, and 20 million were considered refugees. While the geopolitical consequences of such migration continue to be considered, less is known about the impact of these events on the respiratory health of migrants and refugees. In recognition of this knowledge gap, the American Thoracic Society and the European Respiratory Society brought together investigators with diverse and relevant expertise to participate in a workshop and develop a consensus on research needs on the respiratory health of migrants and refugees. The workshop focused on environmental and occupational hazards, chronic noninfectious diseases, and respiratory infectious diseases, which were presented by experts in three distinct sessions, each culminating with panel discussions. A writing committee collected summaries prepared by speakers and other participants, and the information was collated into a single document. Recommendations were formulated, and differences were resolved by discussion and consensus. The group identified important areas of research need, while emphasizing that reducing the burden of pulmonary, critical care, and sleep disorders in migrants and refugees will require a concerted effort by all stakeholders. Using best research practices, considering how research impacts policies affecting migrant and refugee populations, and developing new approaches to engage and fund trainees, clinical investigators, and public health practitioners to conduct high-quality research on respiratory health of migrants and refugees is essential.
KW - Migrants
KW - Refugees
KW - Research needs
KW - Respiratory health
UR - http://www.scopus.com/inward/record.url?scp=85055814211&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055814211&partnerID=8YFLogxK
U2 - 10.1513/AnnalsATS.201807-478ST
DO - 10.1513/AnnalsATS.201807-478ST
M3 - Article
C2 - 30382778
AN - SCOPUS:85055814211
SN - 2325-6621
VL - 15
SP - 1247
EP - 1255
JO - Annals of the American Thoracic Society
JF - Annals of the American Thoracic Society
IS - 11
ER -